Particle Size Determination (NGI)
Reduced variability in results
Increased volumes of test data
Increased productivity
Significant reduction in Health and Safety issues including WR-ULD
Contained handling of drug product, minimising operator exposure
Greatly reduced analyst time spent on labour intensive processes
Upgrade paths throughout the Xelox range
Harmonised testing throughout the Xelox range


Get in contact with us
![[object Object]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fpk0repno%2Fproduction%2Fdbf3a5f83007da9e59edb68fb82b530f003f1265-376x220.png&w=828&q=75)